Sie sind hier: Startseite Personen 31 - Kaier

Dr. rer. pol. Klaus Kaier


Wissenschaftlicher Mitarbeiter

Photo - Klaus Kaier 
E-Mail: kaier@imbi.uni-freiburg.de
Tel.: ++49 (0)761 203-6807
Fax: ++49 (0)761 203-7700
FDM, Ernst-Zermelo-Str. 1
Raum Nr.: 108

Forschungsinteressen

  • Gesundheitsökonomische Modellierungen in der Kardiologie
  • Sekundärdatenanalysen auf Grundlage der DRG-Statistik
  • Gesundheitsökonometrie
  • Netzwerk-Meta-Analysen und die Nutzenbewertung von Arzneimitteln
  • Kosten-Effektivitäts-Analysen in klinischen Studien
  • Ökonomie und Epidemiologie nosokomialer Infektionen
  • Demografischer Wandel und Leistungsinanspruchnahme im stationären Bereich

Projekte

Ausgewählte Publikationen

 
  • Olivier, M., M. Boeker, S. Hanser, P. Hehn und K. Kaier (2019): Der Pflegekomplexmaßnahmen-Score: Paradigmenwechsel im G-DRG System oder Tropfen auf den heißen Stein? Eine Sekundäranalyse auf Basis von Abrechnungsdaten, Gesundheitsökonomie & Qualitätsmanagement 24(04):191-196.
  • Kaier, K., C. Bode, M. Zehender, C. von zur Mühlen und P. Stachon (2019): Modeling the Volume-Outcome Relationship for TAVR. Journal of the American College of Cardiology 74(16):2115-2116.
  • San Martin Rodriguez, M., K. Kaier, M. Hehn und J.P. Borde (2019): Knowledge, habits and attitudes towards TBE and other tick-borne diseases in German forestry trainees. Ticks and Tick-borne Diseases [Epub ahead of print].
  • Zotzmann, V., J. Rilinge, C.N. Lang, K. Kaier, C. Benk, D. Duerschmied, P.M. Biever, C. Bode, T. Wengenmayer und D.L. Staudacher (2019): Epinephrine, inodilator, or no inotrope in venoarterial extracorporeal membrane oxygenation implantation: a single-center experience. Critical Care 23(1):320.
  • Heister, T., M. Wolkewitz, P. Hehn, J. Wolff, M. Dettenkofer, H. Grundmann und K. Kaier (2019): Costs of hospital-acquired Clostridium difficile infections: an analysis on the effect of time-dependent exposures using routine and surveillance data. Cost Effectiveness and Resource Allocation 17:16.
  • Peikert, A., K. Kaier, J. Merz, L. Manhart, I. Schäfer, I. Hilgendorf, P. Hehn, D. Wolf, F. Willecke, X. Sheng, A. Clemens, M. Zehender, C. von Zur Mühlen, C. Bode, A. Zirlik und P. Stachon (2019): Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohort. Clinical Research in Cardiology [Epub ahead of print].
  • Jabbarli, R., D. Pierscianek, R. Rölz, M. Darkwah Oppong, K. Kaier, M. Shah, C. Taschner, C. Mönninghoff, H. Urbach, J. Beck, U. Sure und M. Forsting (2019): Endovascular treatment of cerebral vasospasm after subarachnoid hemorrhage: More is more. Neurology 93(5):e458-e466.
  • Kaier, K., M. Wolkewitz, P. Hehn, N.T. Mutters und T. Heister (2019): The impact of hospital-acquired infectionson the patient-level reimbursement-cost relationshipin a DRG-based hospital payment system. International Journal of Health Economics and Management [Epub ahead of print].
  • Stachon, P., K. Kaier, T. Heidt, W. Bothe, A. Zirlik, M. Zehender, C. Bode und C. von zur Mühlen (2019): Nationwide outcomes of aortic valve replacement for pure aortic regurgitation in Germany 2008–2015. Catheterization and Cardiovascular Interventions [Epub ahead of print].
  • Brühmann, B. A., C. Reese, K. Kaier, M. Ott, C. Maurer, S. Kunert, B. R. Saurer und E. Farin (2019: A complex health services intervention to improve medical care in long-term care homes: study protocol of the controlled coordinated medical care (CoCare) study. BMC Health Services Research 19:332.
  • Al Said, S., S. Alabed, K. Kaier, C. Bode, J.J. Meerpohl und D. Duerschmied (2019): Non-vitamin K antagonist oral anticoagulants (NOACs) post-percutaneous coronary intervention: a network meta-analysis (Protocol). Cochrane Database of Systematic Reviews 1:CD013252.
  • Stachon, P., K. Kaier , A. Zirlik , W. Bothe , T. Heidt , M. Zehender , C. Bode und C. von zur Mühlen (2019): Risk-Adjusted Comparison of In-Hospital Outcomes of Transcatheter and Surgical Aortic Valve Replacement. Journal of the American Heart Association 8(7):e011504.
  • Dammann, P., P. Wittek, M. Darkwah Oppong, B.-O. Hütter, R. Jabbarli, K. Wrede, I. Wanke, C. Mönninghoff, K. Kaier, B. Frank, O. Müller, C. Kleinschnitz, M. Forsting und U. Sure (2019): Relative health-related quality of life after treatment of unruptured intracranial aneurysms: long-term outcomes and influencing factors. Therapeutic Advances in Neurological Disorders 12:1-12.
  • Frank, F., F. Bjerregaard, J. Bengel, E.M. Bitzer, B. Heimbach, K. Kaier, J. Kiekert, L. Krämer, C. Kricheldorff, K. Laubner, A. Maun, G. Metzner, W. Niebling, C. Salm, S. Schütter, J. Seufert, E. Farin und S. Voigt-Radloff (2019): Local, collaborative, stepped and personalised care management for older people with chronic diseases (LoChro): study protocol of a randomised comparative effectiveness trial. BMC Family Geriatrics 19(1):64.
  • Voigt-Radloff, S., A. Schöpf, M. Boeker, L. Frank, E. Farin, K. Kaier, M. Körner, K. Wollmann, B. Lang, J. Meerpohl, R. Möhler, W. Niebling, J. Serong, R. Lange, P. van der Keylen und A. Maun (2019): Well informed physician-patient communication in consultations on back pain - study protocol of the cluster randomized GAP trial. BMC Family Practice 20(1):33.
  • Kaier, K., N.T. Mutters und M. Wolkewitz (2019): Measuring the financial burden of resistance: What should be compared? Clinical Infectious Diseases [Epub ahead of print].
  • Jabbarli, R., T.F Dinger, D. Pierscianek, M. Darkwah Oppong, B. Chen, P. Dammann, K.H. Wrede, K. Kaier, M. Köhrmann, M. Forsting, C. Kleinschnitz und U. Sure (2019): Intracranial aneurysms in sickle cell disease: A systematic review and case-control study, Current Neurovascular Research 16(1):63-76.
  • Kaier, K., C. von zur Mühlen, A. Zirlik, W. Bothe, P. Hehn, M. Zehender, C. Bode und P. Stachon (2019): Estimating the additional costs per life saved due to transcatheter aortic valve replacement: a secondary data analysis of electronic health records in Germany, European Journal of Health Economics 20(4):625-632.
  • Darkwah Oppong, M., O. Gembruch, D. Pierscianek, M. Köhrmann, C. Kleinschnitz, C. Deuschl, C. Mönninghoff, K. Kaier, M. Forsting, U. Sure und R. Jabbarli (2018): Post-treatment Antiplatelet Therapy Reduces Risk for Delayed Cerebral Ischemia due to Aneurysmal Subarachnoid Hemorrhage, Neurosurgery [Epub ahead of print].
  • Adebahr, S., M. Hechtner, N. Schräder, T. Schimek-Jasch, K. Kaier, V.D. Rohr, E. Gkika, F. Momm, J. Gärtner, G. Becker, A.L Grosu und U. Nestle (2019): Early impact of pulmonary stereotactic fractionated body radiotherapy (SBRT) on Quality of Life (QoL): Benefit for patients with low initial scores (STRIPE trial), Journal of Thoracic Oncology 14(3):408-419.
  • Wengenmayer, T., F. Schroth, P.M. Biever, D. Duerschmied, C. Benk, G. Trumme, K. Kaier, C. Bode, D.L. Staudacher (2018): Albumin fluid resuscitation in patients on venoarterial extracorporeal membrane oxygenation (VA-ECMO) therapy is associated with improved survival, Intensive Care Medicine 44(12):2312-2314.
  • Stachon, P., K. Kaier, A. Zirlik, W. Bothe, M. Zehender, C. Bode, C. von zur Mühlen (2018): Die Entwicklung und Ergebnisse von TAVI und chirurgischem Aortenklappenersatz in Deutschland 2014 bis 2015, Deutsche medizinische Wochenschrift 143(23):e206-e212.
  • Engler-Hüsch, S., T. Heister, N.T. Mutters, J. Wolff und K. Kaier (2018): In-hospital costs of community-acquired colonization with multidrug-resistant organisms at a German teaching hospital, BMC Health Services Research 18:737.
  • Jabbarli, R., D. Pierscianek, M. Darkwah Oppong, T. Sato, P. Dammann, K.H. Wrede, K. Kaier, M. Köhrmann, M. Forsting, C. Kleinschnitz, A. Roos und U. Sure (2018): Laboratory biomarkers of delayed cerebral ischemia after subarachnoid hemorrhage: a systematic review, Neurosurgical Review [Epub ahead of print].
  • Kern, W., S. Weber, M. Dettenkofer, K. Kaier, H. Bertz, M. Behnke, M. Weisser, T. Götting, A. Widmer, und C. Theilacker (2018): Impact of fluoroquinolone prophylaxis during neutropenia on bloodstream infection: Data from a surveillance program in 8,755 patients receiving high-dose chemotherapy for haematologic malignancies between 2009 and 2014, Journal of Infection 77:68-74.
  • Kaier, K., V. Oettinger, H.Reinecke, C. Schmoor, L. Frankenstein, P. Hehn, C. von zur Mühlen, C. Bode, M. Zehender und J. Reinöhl (2018): Volume-outcome relationship in transcatheter aortic valve implantations in Germany 2008-2014: a secondary data analysis of electronic health records, BMJ Open 8(7):e020204.
  • Stachon, P., M. Zehender, C. Bode, C. von zur Mühlen and K. Kaier (2018): Development and In-Hospital Mortality of Transcatheter and Surgical Aortic Valve Replacement in 2015 in Germany, Journal of the American College of Cardiology 72(4):475-476.
  • Dietrich, E.S., S. Felder und K. Kaier (2018): Kosten nosokomialer Infektionen. In: Dettenkofer M., Frank U., Just H.-M., Lemmen S., Scherrer M. (Eds.): Praktische Krankenhaushygiene und Umweltschutz. Berlin, Heidelberg: Springer.
  • Kaier, K., M. Wolkewitz und T. Heister (2018): Estimating the attributable costs of hospital-acquired infections requires a distinct categorization of cases based on time of infection, American Journal of Infection Control 46(6):729.
  • Stachon, P., K. Kaier, A. Zirlik, J. Reinöhl, T. Heidt, W. Bothe, P. Hehn, M. Zehender, C. Bode und C. von zur Mühlen (2018): Risk factors and outcome of postoperative delirium after transcatheter aortic valve replacement, Clinical Research in Cardiology 107(9):756-762.
  • Kaier, K., C. von zur Mühlen, A. Zirlik, C. Schmoor, K. Roth, W. Bothe, P. Hehn, J. Reinöhl, M. Zehender, C. Bode und P. Stachon (2018): Sex-specific differences in outcome of transcatheter or surgical aortic valve replacement, Canadian Journal of Cardiology 34(8):992-998.
  • Heister, T., M. Wolkewitz und K. Kaier (2018): Determining the Attributable Costs of Clostridium difficile Infections When Exposure Time Is Lacking: Be Wary of "Conditioning on the Future", Infection Control & Hospital Epidemiology 39(6):759-760.
  • Jabbarli, R., T.F. Dinger, M. Darkwah Oppong, D. Pierscianek, P. Dammann, K.H. Wrede, K. Kaier, M. Köhrmann, M. Forsting, C. Kleinschnitz und U. Sure (2018): Risk Factors for and Clinical Consequences of Multiple Intracranial Aneurysms: A Systematic Review and Meta-Analysis, Stroke 49(4):848-855.
  • Jabbarli, R., D. Pierscianek, R. Rölz, M. Reinhard, M. Darkwah Oppong, C. Scheiwe, P. Dammann, K. Kaier, K.H. Wrede, M. Shah, J. Zentner und U. Sure (2018): Gradual External Ventricular Drainage Weaning Reduces The Risk of Shunt Dependency After Aneurysmal Subarachnoid Hemorrhage: A Pooled Analysis, Operative Neurosurgery 15(5):498-504.
  • Heister, T., M. Wolkewitz und K. Kaier (2018): Estimating the additional costs of surgical site infections: length bias, time-dependent bias, and conditioning on the future, Journal of Hospital Infection 99(1):103-104.
  • Kaier, K., H. Reinecke, H. Nacy, L. Frankenstein, M. Bode, W. Vach, P. Hehn, A. Zirlik, M. Zehender und J. Reinöhl (2018): The impact of post-procedural complications on reimbursement, length of stay and mechanical ventilation among patients undergoing transcatheter aortic valve implantation in Germany, European Journal of Health Economics 19(2):223-228.
  • Wolff, J., T. Heister, C. Normann und K. Kaier (2018): Hospital costs associated with psychiatric comorbidities: a retrospective study, BMC Health Services Research 18(1):67.
  • Gkika, E., W. Vach, S. Adebahr, T. Schimeck-Jasch, A. Brenner, T. Brunner, K. Kaier, A. Prasse, J. Muller-Quernheim, A. Grosu, G. Zissel und U. Nestle (2017): Is serum level of CC chemokine ligand 18 a biomarker for the prediction of radiation induced lung toxicity (RILT)? Plos One 12(9):e0185350.
  • Malyar N.M., K. Kaier, E. Freisinger, F. Lüders, G. Kaleschke, H. Baumgartner, L. Frankenstein, H. Reinecke und J. Reinöhl (2017): Prevalence and Impact of Critical Limb Ischemia on In-Hospital Outcome in Transcatheter Aortic Valve Implantation in Germany, EuroIntervention 13(11):1281-1287.
  • Kaier, K., F. von Kampen, Baumbach, C. von Zur Mühlen, P. Hehn, W. Vach, M. Zehender, C. Bode und J. Reinöhl (2017): Two-year post- discharge costs of care among patients treated with transcatheter or surgical aortic valve replacement in Germany, BMC Health Services Research 17:473.
  • Heister, T., C. Hagist und K. Kaier (2017): Resistance Elasticity of Antibiotic Demand in Intensive Care. Health Economics 26(7):892-909.
  • Gutmann, A., K. Kaier, L. Frankenstein, A. Zirlik, W. Bothe, C. von Zur Mühlen, M. Zehender, J. Reinöhl, C. Bode und P. Stachon (2017): Impact of pulmonary hypertension on in-hospital outcome after surgical or transcatheter aortic valve replacement, EuroIntervention 13(7):804-810.
  • Lüders F., K. Kaier, G. Kaleschke, K. Gebauer, M. Meyborg, N.M. Malyar, E. Freisinger, H. Baumgartner, H. Reinecke und J. Reinöhl (2017): Association of CKD with Outcomes Among Patients Undergoing Transcatheter Aortic Valve Implantation, Clinical Journal of the American Society of Nephrology 12(5):718- 726.
  • Kaier, K., S. Hils, S. Fetzer, P. Hehn, A. Schmid, D. Hauschke, L. Bogatyreva, B. Jänigen und P. Pisarski (2017): Results of a randomized controlled trial analyzing telemedically supported case management in the first year after living donor kidney transplantation - a budget impact analysis from the healthcare perspective, Health Economics Review 7:1.
  • Kaier, K., H. Reinecke, C. Schmoor, L. Frankenstein, W. Vach, P. Hehn, A. Zirlik, C. Bode, M. Zehender und J. Reinöhl (2017): Learning Curves Among All Patients Undergoing Transcatheter Aortic Valve Implantation in Germany: A Retrospective Observational Study, International Journal of Cardiology 235:17-21.
  • Jabbarli, R., M. Reinhard, R. Roelz, K. Kaier, A. Weyerbrock, C. Taschner, C. Scheiwe und M. Shah (2017): Clinical relevance of anterior cerebral artery asymmetry in aneurysmal subarachnoid hemorrhage, J Neurosurg 127(5):1070-1076.
  • Heister, T.,  K. Kaier  und M. Wolkewitz (2017): Estimating the burden of nosocomial infections: Time dependency and cost clustering should be taken into account, American Journal of Infection Control 45(1):94-95.
  • Reinöhl, J., K. Kaier, H. Reinecke, L. Frankenstein, A. Zirlik, M. Zehender, C. von Zur Mühlen, C. Bode und P. Stachon (2016): Transcatheter Aortic Valve Replacement: The New Standard in Patients With Previous Coronary Bypass Grafting? JACC: Cardiovascular Interventions 9(20):2137-2143.
  • Kaier, K., A. Gutmann, H. Baumbach, C. von Zur Mühlen, P. Hehn, W. Vach, F. Beyersdorf, M. Zehender, C. Bode and J. Reinöhl (2016): Quality of life among elderly patients undergoing transcatheter or surgical aortic valve replacement - a model-based longitudinal data analysis, Health and Quality of Life Outcomes 14(1):109.
  • Borde, J.P., S. Nussbaum, S. Hauser, P. Hehn, J. Hübner, G. Sitaru, S. Köller, B. Schweigert, K.d. With, W.V. Kern und K. Kaier (2016): Implementing an intensified antibiotic stewardship programme targeting daptomycin use in orthopaedic surgery: a cost-benefit analysis from the hospital perspective. Infection 44(3):301-307.
  • Jabbarli, R., M. Reinhard, R. Roelz, M. Shah, W.D. Niesen, K. Kaier, C. Taschner, A. Weyerbrock und V. Van Velthoven (2016): Intracerebral Hematoma Due to Aneurysm Rupture: Are There Risk Factors Beyond Aneurysm Location? Neurosurgery 78(6):813-820.
  • Reinöhl, J., D. Psyrakis, K. Kaier, S. Kodirov, M. Siepe, A. Gutmann, C. von Zur Mühlen, M. Moser, I. Ahrens, G. Pache, A. Zirlik, M. Langer, F. Beyersdorf, M. Zehender, C. Bode und P. Blanke (2016): Aortic root volume is associated with contained rupture of the aortic annulus in balloon-expandable transcatheter aortic valve replacement. Catheterization and Cardiovascular Interventions 87(4):807-817.
  • Jabbarli, R., M. Reinhard, M. Shah, R. Roelz, W.D. Niesen, K. Kaier, C. Taschner, A. Weyerbrock und V. Van Velthoven (2016): The predictors and clinical impact of intraventricular hemorrhage in patients with aneurysmal subarachnoid hemorrhage Cerebrovascular Diseases 41(5-6):265-272.
  • Jabbarli, R., M. Reinhard, R. Roelz, M. Shah, W.D. Niesen, K. Kaier, C. Taschner, A. Weyerbrock und V. Van Velthoven (2016): The predictors and clinical impact of intraventricular hemorrhage in patients with aneurysmal subarachnoid hemorrhage International Journal of Stroke 11(1):68-76.
  • Reinöhl J., K. Kaier, H. Reinecke, C. Schmoor, L. Frankenstein, W. Vach, A. Cribier, F. Beyersdorf, C. Bode und M. Zehender (2015): Effect of Availability of Transcatheter Aortic-Valve Replacement on Clinical Practice. New England Journal of Medicine 373(25): 2438-2447.
  • Wolff, J., P. McCrone, A. Patel, K. Kaier und C. Normann (2015): Predictors of length of stay in psychiatry: analyses of electronic medical records. BMC Psychiatry 15:238.
  • Reinöhl, J., K. Kaier, A. Gutmann, S. Sorg, C. von Zur Mühlen, M. Siepe, H. Baumbach, M. Moser, A. Geibel, A. Zirlik, P. Blanke, W. Vach, F. Beyersdorf, C. Bode und M. Zehender (2015): In-hospital resource utilization in surgical and transcatheter aortic valve replacement. BMC Cardiovascular Disorder 15:132.
  • Kaier, K. und C. Müller (2015): New figures on unfunded public pension entitlements across Europe: concept, results and applications, Empirica 42(4): 865-895.
  • Jabbarli, R., M. Reinhard, R. Roelz, M. Shah, W.D. Niesen, K. Kaier, C. Taschner, A. Weyerbrock und V. Van Velthoven (2015): Outcome Prediction after Non-aneurysmal Non-traumatic Subarachnoid Hemorrhage, Current Neurovascular Research 12(3): 269-276.
  • Jabbarli, R., M. Reinhard, R. Roelz, M. Shah, W.D. Niesen, K. Kaier, C. Taschner, A. Weyerbrock und V. Van Velthoven (2015): Early identification of individuals at high risk for cerebral infarction after aneurysmal subarachnoid hemorrhage: the BEHAVIOR score, Journal of Cerebral Blood Flow & Metabolism 35(10): 1587-1592.
  • Jabbarli, R., M. Reinhard, W.D. Niesen, R. Roelz, M. Shah, K. Kaier, B. Hippchen, C. Taschner und V. Van Velthoven (2015): Predictors and impact of early cerebral infarction after aneurysmal subarachnoid hemorrhage, European Journal of Neurology 22(6): 941-947.
  • Stachon, P., K. Kaier, S. Milde, G. Pache, S. Sorg, M. Siepe, C. von zur Mühlen, A. Zirlik, F. Beyersdorf und M. Langer (2015): Two-year survival of patients screened for transcatheter aortic valve replacement with potentially malignant incidental findings in initial body computed tomography, European Heart Journal - Cardiovascular Imaging 16(7): 731-737.
  • Kaier, K. und S. Fetzer (2015): Das Arzneimittelmarktneuordnungsgesetz (AMNOG) aus ökonomischer Sicht, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 58: 291-297.
  • Kaier, K., A. Gutmann, W. Vach, S. Sorg, M. Siepe, C. von Zur Mühlen, M. Moser, P. Blanke, F. Beyersdorf, M. Zehender, C. Bode und J. Reinöhl (2015): " Heart Team" decision making in elderly patients with symptomatic aortic valve stenosis who underwent AVR or TAVI-a look behind the curtain. Results of the prospective TAVI Calculation of Costs Trial (TCCT), EuroIntervention 11(8):793-798.
  • Gutmann, A., K. Kaier, S. Sorg, C. von zur Mühlen, M. Siepe, M. Moser, A. Geibel, A. Zirlik, I. Ahrens, H. Baumbach, F. Beyersdorf, W. Vach, M. Zehender, C. Bode und J. Reinöhl (2015): Analysis of the additional costs of clinical complications in patients undergoing transcatheter aortic valve replacement in the German Health Care System, International Journal of Cardiology 179: 231-237.
  • Borde, J.P., W.V. Kern, M. Hug, M. Steib-Bauert, K.d. With, H.J. Busch und K. Kaier (2015): Implementation of an intensified antibiotic stewardship programme targeting third-generation cephalosporin and fluoroquinolone use in an emergency medicine department, Emergency Medicine Journal 32: 509-515.
  • Borde, J.P., S. Litterst, M. Ruhnke, R. Feik, J. Hübner, K. deWith, K. Kaier und W.V. Kern (2015): Implementing an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a 200-bed community hospital in Germany, Infection 43:45-50.
  • Jabbarli, R., M. Shah, C. Taschner, K. Kaier, B. Hippchen und V. Van Velthoven (2014): Clinical utility and cost-effectiveness of CT-angiography in the diagnosis of nontraumatic subarachnoid hemorrhage, Neuroradiology 56(10): 817-824.
  • Schwander, B., K. Banz, K. Kaier und S. Walzer (2014): Evaluation of a Possible Predictor for Federal Joint Committee Decisions on Early Benefit Assessments according to the German Act on the Reform of the Market for Medicinal Products, Health Policy 117(3): 334-344.
  • Borde, J., N. Batin, S. Rieg, R. Feik, C. Reimling, W. Kern, K. de With, J. Hübner, M. Ruhnke und K. Kaier (2014): Adherence to an antibiotic stewardship bundle targeting Staphylococcus aureus blood stream infections at a 200-bed community hospital, Infection 42(4): 713-71.
  • Kaier, K., M.L. Lambert, U.K. Frank, W. Vach, M. Wolkewitz, E. Tacconelli, J. Rello, U. Theuretzbacher und M. Martin (2014): Impact of availability of guidelines and active surveillance in reducing the incidence of ventilator-associated pneumonia in Europe and worldwide, BMC Infectious Diseases 14(1): 199.
  • Borde, J.P., K. Kaier, M. Steib-Bauert, W. Vach, A. Geibel-Zehender, H. Busch, H. Bertz, M. Hug und W.V. Kern (2014): Feasibility and impact of an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a tertiary care university medical center, BMC Infectious Diseases 14(1): 201.
  • Kaier, K. (2013): The impact of pricing and patent expiration on demand for pharmaceuticals: an examination of the use of broad-spectrum antimicrobials, Health Economics, Policy and Law 8(1): 7-20.
  • Walzer, S., M. Nuijten, C. Wiesner, K. Kaier, P.O. Johansson und S. Oertel (2013): Microeconomic surplus in health care: Applied economic theory in health care in four European countries, Frontiers in Pharmaceutical Medicine and Outcomes Research 4: 17.
  • Kaier, K. und U. Frank (2013): In search of useful methods for measuring health and economic consequences of antimicrobial resistance, Clinical Infectious Diseases 57(8): 1220-1222.
  • Kaier, K. (2012): Eine wohlfahrtsökonomische Analyse der Übernutzung patentfreier Antibiotika und deren Auswirkungen auf die Verbreitung resistenter Infektionserreger, Schmollers Jahrbuch - Journal of Applied Social Science Studies 132(4): 527-548.
  • Kaier, K. und S. Moog (2012): Economic consequences of the demography of MRSA patients and the impact of broad-spectrum antimicrobials, Applied Health Economics and Health Policy 10(4): 227-234.
  • Kaier, K. (2012): Economic modeling of the persistence of antimicrobial resistance, Natural Resource Modeling 25(2): 388-402.
  • Lister, J., S. Stanisic, K. Kaier, C. Hagist, D. Gultyaev und S. Walzer (2012): Societal savings in patients with advanced non-squamous non-small-cell lung cancer receiving bevacizumab-based versus non-bevacizumab-based treatments in France, Germany, Italy, and Spain, ClinicoEconomics and Outcomes Research 4: 299-305.
  • Kaier, K. (2012): Economic implications of the dynamic relationship between antibiotic use and hospital-acquired infections, Value in Health 15(1): 87-93.
  • Kaier, K., N.T. Mutters und U. Frank (2012): Bed occupancy rates and hospital-acquired infections--should beds be kept empty?, Clinical Microbiology and Infection 18(10): 941-945.
  • Kaier, K., C. Wilson, M. Hulscher, H. Wollersheim, A. Huis, M. Borg, E. Scicluna, M.L. Lambert, M. Palomar, E. Tacconelli, G. De Angelis, M. Schumacher, M. Wolkewitz, E.M. Kleissle und U. Frank (2011): Implementing strategic bundles for infection prevention and management, Infection 40(2): 225-228.
  • Kaier, K., E. Huppertz, U. Frank und V. Mersch-Sundermann (2011): Management von Krankenhausinfektionen - Ressourcenverbrauch und Kosteneffektivität, Der Klinikarzt 40(3): 138-141.
  • Kaier, K., U. Frank und E. Meyer (2011): Economic incentives for the (over-)prescription of broad-spectrum antimicrobials in German ambulatory care, Journal of Antimicrobial Chemotherapy 66(7): 1656-1658.
  • Kaier, K., D. Luft, M. Dettenkofer, M. Kist und U. Frank (2011): Correlations between bed occupancy rates and Clostridium difficile infections – A time-series analysis, Epidemiology and Infection 139: 482-485.
  • Kaier, K. und U. Frank (2010): Measuring the Externality of Antibacterial Use from Promoting Antimicrobial Resistance, Pharmacoeconomics 28(12): 1123-1128.
  • Kaier, K., U. Frank, A. Conrad und E. Meyer (2010): Seasonal and Ascending Trends in the Incidence of Carriage of Extended-Spectrum b-Lactamase-Producing Escherichia coli and Klebsiella Species in 2 German Hospitals, Infection Control and Hospital Epidemiology 31(11): 1154-1159.
  • Kaier, K., M. Dettenkofer, E. Meyer und U. Frank (2010): Epidemiology meets econometrics: Using time-series analysis to observe the impact of bed occupancy rates on the spread of multi drug-resistant bacteria, Journal of Hospital Infection 76: 108-113.
  • Conrad, A., K. Kaier, U. Frank und M. Dettenkofer (2010): Are short training sessions on hand hygiene effective in preventing hospital-acquired MRSA? A time-series analysis, American Journal of Infection Control 38(7): 559-561.
  • Kaier, K. und U. Frank (2009): Antimikrobielle Resistenz als externer Effekt des Einsatzes von Antibiotika - Zusammenhänge und Implikationen für die pharmakoökonomische Analyse des klinikinternen Einsatzes von Antibiotika, Gesundheitsökonomie & Qualitätsmanagement 14(03): 127-131.
  • Kaier, K., C. Hagist, U. Frank, A. Conrad und E. Meyer (2009): Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection, Infection Control and Hospital Epidemiology 30(4): 346-353.
  • Kaier, K., U. Frank, C. Hagist, A. Conrad und E. Meyer (2009): The impact of antimicrobial drug consumption and alcohol-based hand rub use on the emergence and spread of extended-spectrum {beta}-lactamase-producing strains: a time-series analysis, Journal of Antimicrobial Chemotherapy 63(3): 609-614.
  • Kaier, K., C. Wilson, M. Chalkley, P. Davey, C. Suetens, H. Grundmann, M. de Kraker, M. Schumacher, M. Wolkewitz und U. Frank (2008): Health and Economic Impacts of Antibiotic Resistance in European Hospitals - Outlook on the BURDEN Project, Infection 36(5): 492-494.

 

Publikationen

Forschungsdatenbank Universität Freiburg:

[2019] [2018] [2017] [2016] [2015] [Ältere Publikationen]

Kurzlebenslauf

Seit 2012 Wissenschaftlicher Mitarbeiter, Institut für Medizinische Biometrie und Statistik des Universitätsklinikums Freiburg
2012 Interdisziplinäre Promotion (Betreuer: Prof. Dr. rer. pol. Bernd Raffelhüschen und Prof. Dr. med. Uwe Frank)
2011-2012 Wissenschaftlicher Mitarbeiter, Department für Infektiologie des Universitätsklinikums Heidelberg
2008-2012 Wissenschaftlicher Mitarbeiter, Institut für Finanzwissenschaft und Sozialpolitik der Albert-Ludwigs-Universität Freiburg
2007-2011 Wissenschaftlicher Mitarbeiter, Institut für Umweltmedizin und Krankenhaushygiene des Universitätsklinikums Freiburg
2003-2007 Studium der Volkswirtschaftslehre an der Albert-Ludwigs-Universität Freiburg und der Universidad de Sevilla
Persönliche Seite bearbeiten